The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Adenovirus: The First Effective In Vivo Gene Delivery Vector
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping
Rommens, J. M., Iannuzzi, M. C., Kerem, B.-S., Drumm, M. L., Melmer, G., Dean, M., Rozmahel, R., Cole, J. L., Kennedy, D., Hidaka, N., et al. (1989) · Science · doi:10.1126/science.2772657 · Cited by 3,253
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.
Yang, Y., Nunes, F. A., Berencsi, K., Furth, E. E., Gönczöl, E., & Wilson, J. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4407 · Cited by 1,575
Russell, S. J., Peng, K.-W., & Bell, J. C. (2012) · Nature Biotechnology · doi:10.1038/nbt.2287 · Cited by 1,428
Rosenfeld, M. A., Yoshimura, K., Trapnell, B. C., Yoneyama, K., Rosenthal, E. R., Dalemans, W., Fukayama, M., Bargon, J., Stier, L. E., Stratford-Perricaudet, L., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90213-v · Cited by 931
Self-citationCrystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C.-S., Mastrangeli, A., Hay, J. G., Brody, S. L., Jaffe, H. A., Eissa, N. T., & Danel, C. (1994) · Nature Genetics · doi:10.1038/ng0994-42 · Cited by 826
Self-citationAdenovirus-Mediated Transfer of a Recombinant α1-Antitrypsin Gene to the Lung Epithelium in Vivo
Rosenfeld, M. A., Siegfried, W., Yoshimura, K., Yoneyama, K., Fukayama, M., Stier, L. E., Pääkkö, P. K., Gilardi, P., Stratford-Perricaudet, L. D., Perricaudet, M., et al. (1991) · Science · doi:10.1126/science.2017680 · Cited by 737
Self-citationZabner, J., Couture, L. A., Gregory, R. J., Graham, S. M., Smith, A. E., & Welsh, M. J. (1993) · Cell · doi:10.1016/0092-8674(93)80063-k · Cited by 681
Rosengart, T. K., Lee, L. Y., Patel, S. R., Sanborn, T. A., Parikh, M., Bergman, G. W., Hachamovitch, R., Szulc, M., Kligfield, P. D., Okin, P. M., et al. (1999) · Circulation · doi:10.1161/01.cir.100.5.468 · Cited by 656
Self-citationReplacement Therapy for Alpha1-Antitrypsin Deficiency Associated with Emphysema
Wewers, M. D., Casolaro, M. A., Sellers, S. E., Swayze, S. C., McPhaul, K. M., Wittes, J. T., & Crystal, R. G. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704233161704 · Cited by 641
Self-citationIdentification of the cystic fibrosis gene.
Knight, R. A., & Hodson, M. E. (1990) · BMJ · doi:10.1136/bmj.300.6721.345 · Cited by 496
Crystal, R. G. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114578 · Cited by 495
Self-citationAdenoviruses as Gene-Delivery Vehicles
Wilson, J. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341809 · Cited by 476
Adenoviruses: update on structure and function
Russell, W. C. (2009) · Journal of General Virology · doi:10.1099/vir.0.003087-0 · Cited by 461
Adenovirus–mediated in vivo gene transfer and expression in normal rat liver
Jaffe, H. A., Danel, C., Longenecker, G., Metzger, M., Setoguchi, Y., Rosenfeld, M. A., Gant, T. W., Thorgeirsson, S. S., Stratford-Perricaudet, L. D., Perricaudet, M., et al. (1992) · Nature Genetics · doi:10.1038/ng0892-372 · Cited by 449
Self-citationYang, Y., Jooss, K. U., Su, Q., Ertl, H. C. J., & Wilson, J. M. (1996) · PubMed · Cited by 375
Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy
Gao, G. P., Yang, Y., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8934-8943.1996 · Cited by 370
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy
Jooss, K., & Chirmule, N. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302037 · Cited by 277
New Insights on Adenovirus as Vaccine Vectors
Lasaro, M. O., & Ertl, H. C. (2009) · Molecular Therapy · doi:10.1038/mt.2009.130 · Cited by 263
Kanerva, A., Mikheeva, G., Krasnykh, V. N., Coolidge, C. J., Lam, J. T., Mahasreshti, P. J., Barker, S., Straughn, M. J., Barnes, M. N., Alvarez, R. D., et al. (2002) · PubMed · Cited by 255
Sato, N., Leopold, P. L., & Crystal, R. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7691 · Cited by 253
Self-citationHarvey, B.-G., Leopold, P. L., Hackett, N. R., Grasso, T. M., Williams, P. M., Tucker, A. L., Kaner, R. J., Ferris, B., Gonda, I., Sweeney, T. D., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7935 · Cited by 245
Self-citationHartman, Z. C., Appledorn, D. M., & Amalfitano, A. (2008) · Virus Research · doi:10.1016/j.virusres.2007.10.005 · Cited by 239
Rosengart, T. K., Lee, L. Y., Patel, S. R., Kligfield, P. D., Okin, P. M., Hackett, N. R., Isom, O. W., & Crystal, R. G. (1999) · Annals of Surgery · doi:10.1097/00000658-199910000-00002 · Cited by 208
Self-citationMastrangeli, A., Harvey, B.-G., Yao, J., Wolff, G., Kovesdi, I., Crystal, R. G., & Falck-Pedersen, E. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.1-79 · Cited by 204
Self-citationSuicide gene therapy in cancer: Where do we stand now?
Duarte, S., Carle, G., Faneca, H., Lima, M. C. P. D., & Pierrefite-Carle, V. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.05.023 · Cited by 202
Mack, C. A., Song, W.-R., Carpenter, H., Wickham, T. J., Kovesdi, I., Harvey, B.-G., Magovern, C. J., Isom, O. W., Rosengart, T., Falck-Pedersen, E., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.1-99 · Cited by 192
Self-citationAdenoviral Vector Immunity: Its Implications and Circumvention Strategies
S. Ahi, Y., S. Bangari, D., & K. Mittal, S. (2011) · Current Gene Therapy · doi:10.2174/156652311796150372 · Cited by 185
Current Strategies and Future Directions for Eluding Adenoviral Vector Immunity
Bangari, D. S., & Mittal, S. K. (2006) · Current Gene Therapy · doi:10.2174/156652306776359478 · Cited by 175
The influence of innate and pre‐existing immunity on adenovirus therapy
Zaiss, A. K., Machado, H. B., & Herschman, H. R. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22328 · Cited by 159
Advances and Future Challenges in Adenoviral Vector Pharmacology and Targeting
Khare, R., Chen, C. Y., Weaver, E. A., & Barry, M. A. (2011) · Current Gene Therapy · doi:10.2174/156652311796150363 · Cited by 159
Zuckerman, J. B., Robinson, C. B., M, K. S., SHELL, R. D., Sferra, T. J., Chirmule, N. B., Magosin, S., PROPERT, K. J., Brown-Parr, E. C., Hughes, J. V., et al. (1999) · Human Gene Therapy · doi:10.1089/10430349950016384 · Cited by 156
High-Capacity “Gutless” Adenoviral Vectors
Schiedner, G., Clemens, P. R., Volpers, C., & Kochanek, S. (2002) · Elsevier eBooks · doi:10.1016/b978-012199504-1/50016-x · Cited by 137
Worgall, S., Leopold, P. L., Wolff, G., Ferris, B., van Roijen, N., & Crystal, R. G. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.14-1675 · Cited by 135
Self-citationHarvey, B., Maroni, J. M., O'Donoghue, K. A., Chu, K. W., Muscat, J. C., Pippo, A. L., Wright, C. E., Hollmann, C., Wisnivesky, J. P., Kessler, P., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340152712638 · Cited by 132
Self-citationMack, C. A., Magovern, C. J., Budenbender, K. T., Patel, S. R., Schwarz, E. A., ZANZONICO, P. B., Ferris, B., Sanborn, T. A., Isom, O. W., Crystal, R. G., et al. (1998) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(98)70236-8 · Cited by 131
Self-citationAdenovirus receptors and their implications in gene delivery
Sharma, A., Li, X., Bangari, D. S., & Mittal, S. K. (2009) · Virus Research · doi:10.1016/j.virusres.2009.02.010 · Cited by 127
Clinical development directions in oncolytic viral therapy
Eager, R. M., & Nemunaitis, J. J. (2011) · Cancer Gene Therapy · doi:10.1038/cgt.2011.7 · Cited by 110
Strategies to overcome host immunity to adenovirus vectors in vaccine development
Thacker, E. E., Timares, L., & Matthews, Q. L. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.29 · Cited by 110
The Challenge for Gene Therapy: Innate Immune Response to Adenoviruses
Thaçi, B., Ulasov, I. V., Wainwright, D. A., & Lesniak, M. S. (2011) · Oncotarget · doi:10.18632/oncotarget.231 · Cited by 109
Evading the immune response upon in vivo gene therapy with viral vectors.
Sack, B. K., & Herzog, R. W. (2009) · PubMed · Cited by 106
Adenovirus signalling in entry
Wolfrum, N., & Greber, U. F. (2012) · Cellular Microbiology · doi:10.1111/cmi.12053 · Cited by 89
Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors
Seregin, S. S., & Amalfitano, A. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903307388 · Cited by 87
Adenoviruses Types, Cell Receptors and Local Innate Cytokines in Adenovirus Infection
Chen, R., & Lee, C. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.823420 · Cited by 87
Functions of the adenovirus E4 proteins and their impact on viral vectors
Weitzman, M. D. (2005) · Frontiers in bioscience · doi:10.2741/1604 · Cited by 85
Oncolytic Adenoviruses for Cancer Immunotherapy
Cerullo, V., Koski, A., Vähä-Koskela, M. J. V., & Hemminki, A. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-398342-8.00008-2 · Cited by 85
Helper-dependent adenoviral vectors for liver-directed gene therapy
Brunetti‐Pierri, N., & Ng, P. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr143 · Cited by 81
Cytotoxic immunotherapy strategies for cancer: Mechanisms and clinical development
Aguilar, L. K., Guzik, B. W., & Aguilar-Córdova, E. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23126 · Cited by 79
Crystal, R. G., Harvey, B., Wisnivesky, J. P., O'Donoghue, K. A., Chu, K. W., Maroni, J. M., Muscat, J. C., Pippo, A. L., Wright, C. E., Kaner, R. J., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340152712647 · Cited by 78
Self-citationGinsberg, H. S. (1984) · Springer eBooks · doi:10.1007/978-1-4684-7935-5 · Cited by 73
Adenovirus Strategies for Tissue-Specific Targeting
Beatty, M. S., & Curiel, D. T. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-398342-8.00002-1 · Cited by 71
Wee, S., Hicks, M. J., De, B. P., Rosenberg, J. B., Moreno, A. Y., Kaminsky, S. M., Janda, K. D., Crystal, R. G., & Koob, G. F. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.200 · Cited by 71
Self-citationGarver, R. I., Chytil, A. M., Karlsson, S., Fells, G. A., Brantly, M., Courtney, M., Kantoff, P. W., Nienhuis, A. W., Anderson, W. F., & Crystal, R. G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.4.1050 · Cited by 71
Self-citationGenetic cancer vaccines: current status and perspectives
Aurisicchio, L., & Ciliberto, G. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.689279 · Cited by 71
Antivector and antitransgene host responses in gene therapy.
Hackett, N. R., Kaminsky, S. M., Sondhi, D., & Crystal, R. G. (2000) · PubMed · Cited by 66
Self-citationVirus chimeras for gene therapy, vaccination, and oncolysis: adenoviruses and beyond
Kaufmann, J. K., & Nettelbeck, D. M. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.04.008 · Cited by 65
Hicks, M. J., De, B. P., Rosenberg, J. B., Davidson, J. T., Moreno, A. Y., Janda, K. D., Wee, S., Koob, G. F., Hackett, N. R., Kaminsky, S. M., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.280 · Cited by 63
Self-citationTan, Y., Hackett, N. R., Boyer, J. L., & Crystal, R. G. (2003) · Human Gene Therapy · doi:10.1089/104303403322542310 · Cited by 63
Self-citationBangari, D. S., Shukla, S., & Mittal, S. K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.099 · Cited by 63
Adenovirus-mediated cancer gene therapy and virotherapy (Review).
Fukazawa, T., Matsuoka, J., Yamatsuji, T., et al. (2010) · PubMed · Cited by 59
Oncolytic adenoviruses targeted to cancer stem cells
Short, J. J., & Curiel, D. T. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0367 · Cited by 58
Patel, S. R., Lee, L. Y., Mack, C. A., Polce, D. R., El-Sawy, T., Hackett, N. R., Ilercil, A., Jones, E. C., Hahn, R. T., Isom, O. W., et al. (1999) · Human Gene Therapy · doi:10.1089/10430349950018012 · Cited by 55
Self-citationHashimoto, M., Boyer, J. L., Hackett, N. R., Wilson, J. M., & Crystal, R. G. (2005) · Infection and Immunity · doi:10.1128/iai.73.10.6885-6891.2005 · Cited by 52
Self-citationAdvances in Helper-Dependent Adenoviral Vector Research
Segura, M. M., Alba, R., Bosch, A., & Chillón, M. (2008) · Current Gene Therapy · doi:10.2174/156652308785160647 · Cited by 52
Adenovirus-Based Genetic Vaccines for Biodefense
Boyer, J. L., Kobinger, G., Wilson, J. M., & Crystal, R. G. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.157 · Cited by 51
Self-citationCapsid-Incorporation of Antigens into Adenovirus Capsid Proteins for a Vaccine Approach
Matthews, Q. L. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100214b · Cited by 50
Chiuchiolo, M. J., Boyer, J. L., Krause, A., Senina, S., Hackett, N. R., & Crystal, R. G. (2006) · The Journal of Infectious Diseases · doi:10.1086/507644 · Cited by 50
Self-citationRaper, S. E., Haskal, Z. J., Ye, X., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.5-671 · Cited by 48
Choi, I.-K., & Yun, C.-O. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2012.95 · Cited by 45
Rapid/Sustained Anti-anthrax Passive Immunity Mediated by Co-administration of Ad/AAV
De, B. P., Hackett, N. R., Crystal, R. G., & Boyer, J. L. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300344 · Cited by 45
Self-citationAnti-Cocaine Vaccine Based on Coupling a Cocaine Analog to a Disrupted Adenovirus
Koob, G. F., Hicks, M. J., Wee, S., Rosenberg, J. B., De, B. P., Kaminksy, S. M., Moreno, A. Y., Janda, K. D., & Crystal, R. G. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711799219334 · Cited by 41
Self-citationEngineered adenovirus serotypes for overcoming anti-vector immunity
Dharmapuri, S., Peruzzi, D., & Aurisicchio, L. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903187053 · Cited by 38
Kasuya, K., Boyer, J. L., Tan, Y., Alipui, D. O., Hackett, N. R., & Crystal, R. G. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.10.018 · Cited by 36
Self-citationDe, B. P., Pagovich, O. E., Hicks, M. J., Rosenberg, J. B., Moreno, A. Y., Janda, K. D., Koob, G. F., Worgall, S., Kaminsky, S. M., Sondhi, D., et al. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.163 · Cited by 34
Self-citationBoyer, J. L., Sofer-Podesta, C., Ang, J., Hackett, N. R., Chiuchiolo, M. J., Senina, S., Perlin, D. S., & Crystal, R. G. (2010) · Human Gene Therapy · doi:10.1089/hum.2009.148 · Cited by 33
Self-citationSofer-Podesta, C., Ang, J., Hackett, N. R., Senina, S., Perlin, D. S., Crystal, R. G., & Boyer, J. L. (2009) · Infection and Immunity · doi:10.1128/iai.00856-08 · Cited by 33
Self-citationDesign of Improved Oncolytic Adenoviruses
Alemany, R. (2012) · Advances in cancer research · doi:10.1016/b978-0-12-398342-8.00004-5 · Cited by 32
T-cell immunity generated by recombinant adenovirus vaccines
Yang, T. C., Millar, J., Grinshtein, N., Bassett, J. D., Finn, J. D., & Bramson, J. L. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.3.347 · Cited by 29
CD40‐targeted adenoviral cancer vaccines: the long and winding road to the clinic
Hangalapura, B. N., Timares, L., Oosterhoff, D., Scheper, R. J., Curiel, D. T., & de Gruijl, T. D. (2012) · The Journal of Gene Medicine · doi:10.1002/jgm.1648 · Cited by 26
Adenovirus-mediated Transgene-engineered Dendritic Cell Vaccine of Cancer
Wu, Q., Xia, D., Carlsen, S. A., & Xiang, J. (2005) · Current Gene Therapy · doi:10.2174/1566523053544272 · Cited by 25
Advancements in adenoviral based virotherapy for ovarian cancer
Matthews, K. S., Alvarez, R. D., & Curiel, D. T. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.012 · Cited by 24
Blarcom, T. J. V., Sofer-Podesta, C., Ang, J., Boyer, J. L., Crystal, R. G., & Georgiou, G. (2010) · Gene Therapy · doi:10.1038/gt.2010.42 · Cited by 21
Self-citationDelivery of Antigens by Viral Vectors for Vaccination
Krause, A., & Worgall, S. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.84 · Cited by 20
Virus Infection Recognition and Early Innate Responses to Non-Enveloped Viral Vectors
Shayakhmetov, D. M. (2010) · Viruses · doi:10.3390/v2010244 · Cited by 18
Potential of helper-dependent adenoviral vectors in modulating airway innate immunity.
Kushwah, R., Cao, H., & Hu, J. (2007) · PubMed · Cited by 17
TAA/ecdCD40L adenoviral prime-protein boost vaccine for cancer and infectious diseases
Deisseroth, A. B., Tang, Y., Zhang, L., Akbulut, H., & Habib, N. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2012.87 · Cited by 12
Cancer therapy with local oncolysis and topical cytokine secretion
Tagawa, M., Kawamura, K., 植山, 太., Nakamura, M., Tada, Y., 馬, 光., Li, Q., Suzuki, N., Shimada, H., & Ochiai, T. (2007) · Frontiers in bioscience · doi:10.2741/2867 · Cited by 10
Double-Blinded, Placebo-Controlled, Randomized Gene Therapy Using Surgery for Vector Delivery
Crystal, R. G., Kaminsky, S. M., Hackett, N. R., & Rosengart, T. K. (2012) · Human Gene Therapy · doi:10.1089/hum.2012.062 · Cited by 8
Self-citationGenetic medicine strategies to protect against bioterrorism.
Boyer, J. L., & Crystal, R. G. (2006) · PubMed · Cited by 4
Self-citation
Cited by
Viral vector platforms within the gene therapy landscape
Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L., & Gao, G. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00487-6 · Cited by 1,404
Immune Responses to Viral Gene Therapy Vectors
Shirley, J. L., de Jong, Y. P., Terhorst, C., & Herzog, R. W. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.01.001 · Cited by 788
Lee, C. S., Bishop, E. S., Zhang, R., Yu, X., Farina, E. M., Yan, S., Zhao, C., Zeng, Z., Shu, Y., Wu, X., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.04.001 · Cited by 691
Gene Therapy Leaves a Vicious Cycle
Goswami, R., Subramanian, G., Silayeva, L., Newkirk, I., Doctor, D., Chawla, K., Chattopadhyay, S., Chandra, D., Chilukuri, N., & Betapudi, V. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00297 · Cited by 347
Gene therapy: Comprehensive overview and therapeutic applications
Sayed, N., Allawadhi, P., Khurana, A., Singh, V., Navik, U., Pasumarthi, S. K., Khurana, I., Banothu, A. K., Weiskirchen, R., & Bharani, K. K. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120375 · Cited by 337
Metadata
- Authors
- Crystal, R. G.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 2014-01
- Volume
- 25
- Issue
- 1
- Pages
- 3-11
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2028266585
- Cited by
- 341
- References
- 90
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.